OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial
Jia Liu, Wei Yang, Yue Liu, et al.
Phytomedicine (2021) Vol. 91, pp. 153671-153671
Open Access | Times Cited: 58
Jia Liu, Wei Yang, Yue Liu, et al.
Phytomedicine (2021) Vol. 91, pp. 153671-153671
Open Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
Interleukin-6 blocking agents for treating COVID-19: a living systematic review
Lina Ghosn, Anna Chaimani, Theodoros Evrenoglou, et al.
Cochrane library (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 157
Lina Ghosn, Anna Chaimani, Theodoros Evrenoglou, et al.
Cochrane library (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 157
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
Haiyu Xu, Shufen Li, Jiayuan Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 76
Haiyu Xu, Shufen Li, Jiayuan Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 76
Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey
Jing Hong, Xiao-wan Xu, Jing Yang, et al.
Journal of Integrative Medicine (2021) Vol. 20, Iss. 1, pp. 34-44
Open Access | Times Cited: 82
Jing Hong, Xiao-wan Xu, Jing Yang, et al.
Journal of Integrative Medicine (2021) Vol. 20, Iss. 1, pp. 34-44
Open Access | Times Cited: 82
Traditional Chinese medicine against COVID-19: Role of the gut microbiota
Zhihua Yang, Yangxi Liu, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112787-112787
Open Access | Times Cited: 42
Zhihua Yang, Yangxi Liu, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112787-112787
Open Access | Times Cited: 42
ETCM v2.0: An update with comprehensive resource and rich annotations for traditional Chinese medicine
Yanqiong Zhang, Xin Li, Yulong Shi, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2559-2571
Open Access | Times Cited: 36
Yanqiong Zhang, Xin Li, Yulong Shi, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2559-2571
Open Access | Times Cited: 36
Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 26
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 26
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review
Irma Rahayu Latarissa, Anna Meiliana, Ida Paulina Sormin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Irma Rahayu Latarissa, Anna Meiliana, Ida Paulina Sormin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Effect and Safety of Fuzheng Huazhuo Decoction against Prolonged SARS-CoV-2 Clearance: A Retrospective Cohort Study
Wen Zhang, Hongze Wu, Xiangru Xu, et al.
Chinese Journal of Integrative Medicine (2025)
Closed Access
Wen Zhang, Hongze Wu, Xiangru Xu, et al.
Chinese Journal of Integrative Medicine (2025)
Closed Access
Effect of Chinese herbal medicine (CHM) as an adjunctive therapy in distinct stages of patients with COVID-19: A systematic review and meta-analysis
Jin-Min Gu, Shu-Nan Zhang, Si-Yao Xiao, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318892-e0318892
Open Access
Jin-Min Gu, Shu-Nan Zhang, Si-Yao Xiao, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318892-e0318892
Open Access
The efficacy of different traditional Chinese medicine treatment for Corona Virus Disease 2019: Systematic Review and Meta-analysis
S U Youzhu, Rui Su, Shuo Wang, et al.
Journal of Herbal Medicine (2025), pp. 101001-101001
Open Access
S U Youzhu, Rui Su, Shuo Wang, et al.
Journal of Herbal Medicine (2025), pp. 101001-101001
Open Access
Effect of Traditional Chinese Medicine on COVID-19 Treatment: A Meta-Analysis of Randomized Clinical Trials
Marharyta Sobczak, Rafał Pawliczak
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 357-357
Open Access
Marharyta Sobczak, Rafał Pawliczak
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 357-357
Open Access
Insights on Add-On Effectiveness of Chinese Herbal Formulas in COVID-19 : An Overview of Systematic Reviews
Bo Li, Yiying Wang, Le-Yan Hu, et al.
European Journal of Integrative Medicine (2025), pp. 102440-102440
Open Access
Bo Li, Yiying Wang, Le-Yan Hu, et al.
European Journal of Integrative Medicine (2025), pp. 102440-102440
Open Access
Identification of potential anti-pneumonia pharmacological components of Glycyrrhizae Radix et Rhizoma after the treatment with Gan An He Ji oral liquid
Xiaojuan Jiang, Lin Yi-Hua, Yun‐Long Wu, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 12, Iss. 6, pp. 839-851
Open Access | Times Cited: 24
Xiaojuan Jiang, Lin Yi-Hua, Yun‐Long Wu, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 12, Iss. 6, pp. 839-851
Open Access | Times Cited: 24
New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches
Kexin Jia, Yijie Li, Tiegang Liu, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 157-168
Open Access | Times Cited: 13
Kexin Jia, Yijie Li, Tiegang Liu, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 157-168
Open Access | Times Cited: 13
Active metabolites combination therapies: towards the next paradigm for more efficient and more scientific Chinese medicine
Quan Gao, Hao Wu, Min Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Quan Gao, Hao Wu, Min Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
SoFDA: an integrated web platform from syndrome ontology to network-based evaluation of disease–syndrome–formula associations for precision medicine
Yanqiong Zhang, Ning Wang, Xia Du, et al.
Science Bulletin (2022) Vol. 67, Iss. 11, pp. 1097-1101
Closed Access | Times Cited: 21
Yanqiong Zhang, Ning Wang, Xia Du, et al.
Science Bulletin (2022) Vol. 67, Iss. 11, pp. 1097-1101
Closed Access | Times Cited: 21
Traditional Chinese Medicines Against COVID-19
Chang-Liang Yao, Wenlong Wei, Jian-Qing Zhang, et al.
World Journal of Traditional Chinese Medicine (2022) Vol. 8, Iss. 3, pp. 279-313
Open Access | Times Cited: 19
Chang-Liang Yao, Wenlong Wei, Jian-Qing Zhang, et al.
World Journal of Traditional Chinese Medicine (2022) Vol. 8, Iss. 3, pp. 279-313
Open Access | Times Cited: 19
Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease
Haohao Yan, Rui Zhang, Xiaoping Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 37
Open Access | Times Cited: 11
Haohao Yan, Rui Zhang, Xiaoping Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 37
Open Access | Times Cited: 11
Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19
Fangbo Zhang, Feifei Guo, Yi Zhang, et al.
Phytomedicine (2022) Vol. 109, pp. 154549-154549
Open Access | Times Cited: 16
Fangbo Zhang, Feifei Guo, Yi Zhang, et al.
Phytomedicine (2022) Vol. 109, pp. 154549-154549
Open Access | Times Cited: 16
Herbal Medicine Intervention for the Treatment of COVID-19: A Living Systematic Review and Cumulative Meta-Analysis
Lin Ang, Eunhye Song, Xiao-Yang Hu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Lin Ang, Eunhye Song, Xiao-Yang Hu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial
Xiangru Xu, Shuang Zhou, Caiyu Chen, et al.
Phytomedicine (2022) Vol. 108, pp. 154514-154514
Open Access | Times Cited: 14
Xiangru Xu, Shuang Zhou, Caiyu Chen, et al.
Phytomedicine (2022) Vol. 108, pp. 154514-154514
Open Access | Times Cited: 14
Effect and mechanism of quercetin or quercetin‐containing formulas against COVID ‐19: From bench to bedside
Jhong Yuan Chen, Tsung Rung Huang, Shih Yun Hsu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2597-2618
Closed Access | Times Cited: 2
Jhong Yuan Chen, Tsung Rung Huang, Shih Yun Hsu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2597-2618
Closed Access | Times Cited: 2
Phytochemistry and Pharmacology of Sesquiterpenoids from Atractylodes DC. Genus Rhizomes
Zhengyi Qu, Hongqun Liu, Zhenghai Zhang, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1379-1379
Open Access | Times Cited: 2
Zhengyi Qu, Hongqun Liu, Zhenghai Zhang, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1379-1379
Open Access | Times Cited: 2
Cytokine Storm in COVID-19: Insight into Pathological Mechanisms and Therapeutic Benefits of Chinese Herbal Medicines
Qingyuan Yu, Xian Zhou, Rotina Kapini, et al.
Medicines (2024) Vol. 11, Iss. 7, pp. 14-14
Open Access | Times Cited: 2
Qingyuan Yu, Xian Zhou, Rotina Kapini, et al.
Medicines (2024) Vol. 11, Iss. 7, pp. 14-14
Open Access | Times Cited: 2
